Cell and Gene Therapy

The MSc in Cell and Gene Therapy at University College London offers a comprehensive and cutting-edge education designed to prepare students for a leading role in the rapidly advancing field of regenerative medicine. This multidisciplinary programme integrates fundamental principles of cell biology, molecular genetics, and bioengineering to provide students with a deep understanding of the development, manufacturing, and clinical application of innovative cell and gene-based therapies. Throughout the course, students gain essential knowledge on the mechanisms of genetic modification, stem cell biology, immunology, and tissue engineering, enabling them to critically evaluate current research, technological advances, and regulatory considerations within this dynamic sector.

The programme features a blend of theoretical coursework and practical training, including laboratory work, seminars, and industry collaborations, fostering the development of critical thinking, research skills, and technical expertise. Students are exposed to state-of-the-art techniques such as gene editing technologies, viral vector design, cell culture methods, and bioprocessing strategies that are vital for translational research and commercial development. Furthermore, the programme emphasizes the importance of ethical, legal, and societal issues related to gene editing and cell therapy, preparing graduates to navigate complex regulatory landscapes responsibly.

Designed for individuals aiming to pursue careers in academia, biotechnology, pharmaceuticals, or healthcare industries, the MSc in Cell and Gene Therapy provides a robust foundation for innovation and entrepreneurship in this transformative field. The programme is delivered by leading academics and industry experts who are actively involved in cutting-edge research and product development. With access to UCL's extensive research facilities and collaborations with industry partners, students have unique opportunities to engage in projects directly linked to current developments in the sector.

Graduates of this programme will be equipped with the advanced knowledge and practical skills necessary to contribute effectively to research teams, clinical trials, and the development of novel therapies. They will be well-positioned to continue in doctoral studies or to enter the biotechnology and pharmaceutical sectors, supporting the growth of personalized medicine and regenerative treatments worldwide. The MSc in Cell and Gene Therapy at UCL truly embodies the university’s commitment to innovation, scientific excellence, and societal impact in healthcare.

The degree covers all aspects of the subject, including basic biomedical science, molecular basis of disease, current and developing technologies and clinical applications. Students also receive vocational training in research methodology and statistics, how to perform a research project and complete a practical laboratory-based project.

Students undertake modules to the value of 180 credits.

The programme consists of four core modules (60 credits), four optional modules (60 credits) and a research dissertation (60 credits).

A Postgraduate Diploma (120 credits, full-time nine months or flexible up to five years) is offered

A Postgraduate Certificate (60 credits, full-time 12 weeks, part-time nine months, or up to two years flexible) is offered.

Core modules

• Molecular Aspects of Cell and Gene Therapy
• Clinical Applications of Cell and Gene Therapy
• Research Methodology and Statistics
• Stem Cell and Tissue Repair

Research Methodology and Statistics is not a core module for the PG Certificate. Students of the PG Certificate can choose an optional module.

Optional modules

• Foundations of Biomedical Sciences
• Applied Genomics
• HIV Frontiers from Research to Clinics
• Molecular and Genetic Basis of Paediatric Disease
• Understanding Research and Critical Appraisal: Biomedicine
• Laboratory Methods in Biomedical Science
• Research Methodology and Statistics

Dissertation/report

All MSc students undertake an independent research project which culminates in a dissertation.

Teaching and learning

Teaching includes lectures, seminars, problem classes and tutorials. Assessment varies depending on the module, but includes written coursework, multiple-choice questions, written examinations, a practical analysis examination and the dissertation.

Applicants should be: a qualified medical practitioner, with a qualification equivalent to a UK MBBS; a non-clinical scientist with a minimum of an upper second-class BSc or equivalent in a life or biomedical science subject; or a healthcare, pharmaceutical or biotech professional and scientist with equivalent experience (minimum of three years).

The MSc in Cell and Gene Therapy at University College London offers a range of financing options to support students throughout their studies. The program primarily provides information on tuition fees, scholarships, bursaries, and other financial assistance available to both UK/EU and international students. Tuition fees are set annually and can vary depending on the student’s residency status. For UK students, the fees are competitive and are aligned with those of similar science postgraduate programs at UCL. International students typically pay higher tuition fees, reflecting the university’s policy on overseas fees, which are also reviewed annually.

Students are encouraged to explore various scholarship opportunities offered directly by UCL as well as external sources. UCL Scholarships for Postgraduate students include a variety of funding options based on merit, financial need, or specific criteria such as research interests or country of residence. These scholarships can cover partial or full tuition fees, and some also include living cost stipends. Additionally, UCL offers bursaries, which are means-tested and aim to assist students with financial challenges during their studies.

Students are also advised to consider external funding options such as government-sponsored loans, research councils, and private foundations that support postgraduate education in health sciences and biomedical fields. Many students may also qualify for student loans through their home country’s government schemes or international financial aid programs.

The university provides detailed guidance on the application process for scholarships and financial aid, with deadlines typically aligned with the admissions cycle. It is recommended that prospective students begin their funding applications early to ensure timely processing and to maximize their chances of receiving financial assistance. Furthermore, UCL’s Careers Service offers advice on part-time work opportunities available to postgraduate students, which can help offset living expenses during the course of the program.

In conclusion, while specific details about program fees and scholarships are updated annually and vary for different student categories, UCL’s comprehensive financial support system aims to make postgraduate study in Cell and Gene Therapy accessible to a diverse student body. Prospective students should regularly consult the official UCL website for the latest information regarding tuition fees, scholarship opportunities, and financial guidance specific to their circumstances.

The MSc in Cell and Gene Therapy at University College London offers an advanced, comprehensive curriculum designed to equip students with both theoretical knowledge and practical skills relevant to the rapidly evolving field of regenerative medicine and innovative therapeutic strategies. This programme aims to address the growing demand for specialists capable of developing, assessing, and applying cutting-edge cell and gene techniques for the treatment of various diseases, including cancer, genetic disorders, and other chronic conditions. Students will explore fundamental scientific principles behind cellular and genetic modification, including gene editing technologies such as CRISPR-Cas9, stem cell biology, and virus-based vectors. The programme integrates multidisciplinary approaches, combining principles from molecular biology, immunology, bioinformatics, and clinical applications, to prepare graduates for careers in academia, industry, and healthcare settings. Coursework includes theoretical modules, laboratory-based research projects, and opportunities for collaboration with leading research institutes and industry partners. Graduates will be competent in designing and conducting experiments, critically analyzing scientific data, and understanding the ethical and regulatory frameworks governing advanced therapies. The programme also emphasizes the importance of translating scientific findings into practical treatments, fostering innovation, and understanding the commercialization process. With UCL's strong links to biomedical research centres and biotech industries, students may benefit from guest lectures, seminars, and networking events that connect academic insights with industry needs. The MSc typically lasts one year full-time, with options for part-time study. Applicants should have a relevant scientific background, such as in biology, biochemistry, molecular biology, or related disciplines. Admission requirements generally include an undergraduate degree with a good academic record, relevant experience, and a motivation to contribute to the development of novel cell and gene therapies. This programme prepares students to pursue careers in clinical research, biotechnology companies, regulatory agencies, and academia, contributing to advancements in personalized medicine and regenerative therapies.